Business Context and Reporting Period
This Form 8-K Current Report was filed by Ares Capital Corporation on January 18, 2022. The report discloses a significant capital raising event involving the issuance of common stock pursuant to a Purchase Agreement dated January 12, 2022.
Key Financial Metrics
- Shares Issued: 10,000,000 shares of common stock.
- Offering Price: $21.06 per share.
- Net Proceeds: Approximately $210.2 million (after deducting discounts, commissions, and estimated offering expenses).
- Over-Allotment Option: Underwriters were granted an option to purchase an additional 1,500,000 shares, exercisable for 30 days from the Purchase Agreement date.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this report focuses solely on the equity issuance event.
Material Changes
The primary material change is the increase in outstanding common stock and the infusion of approximately $210.2 million in net capital. This transaction was executed with underwriters including Morgan Stanley & Co. LLC, BofA Securities, Inc., and UBS Securities LLC.
Outlook, Risks, and Management Commentary
The filing does not contain specific management commentary on future outlook, risks, or contingencies beyond the standard disclosure that the description of the Purchase Agreement is qualified by reference to the full text of the agreement filed as Exhibit 1.1. The transaction was conducted pursuant to a Registration Statement on Form N-2.
Investor Verification Checklist
- Verify the full terms of the Purchase Agreement in Exhibit 1.1.
- Confirm whether the underwriters exercised the option to purchase the additional 1,500,000 shares within the 30-day window.
- Review the updated total share count and capitalization structure following this issuance.
- Check subsequent filings for the specific allocation of the $210.2 million in net proceeds.